Eton Pharmaceuticals
NASDAQ: ETONSan Diego, US · Founded 2017 · Delaware corporation · 59 employees on LinkedIn
Find your way into Eton Pharmaceuticals
Sign up to see every warm intro you have to Eton Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eton Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products, including injectable and rare disease treatments. Its leadership team has experience across pharmaceutical product development, commercialization, quality/GxP compliance, and finance.
Founders & leadership
Eton Pharmaceuticals was founded in 2017 by Sean E. Brynjelsen.


Board
Reported raises · per SEC filings
Form D private placements$27.6M disclosed across 2 rounds · 2017–2020
▶$7.5MraisedApr 2020 · 2 investors · PharmaceuticalsRule 506(b)
- Mark L BaumDirector
- William Wilson TroutmanExecutive Officer
- Sean BrynjelsenExecutive Officer, Director
- Charles J CasamentoDirector
- Paul V MaierDirector
- Norbert G RiedelDirector
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$20.1MraisedJun 2017 · 230 investors · PharmaceuticalsRule 506(b)
- Charles CasamentoDirector
- Mark BaumDirector
- Andrew BollDirector
- Sean BrynjelsenExecutive Officer, Director
- Offering amount
- $20.1M
- Amount sold
- $20.1M
- Sales commissions
- $2M
- Placement agents
- National Securities Corporation
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Eton Pharmaceuticals went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Eton Pharmaceuticals.
In the news
Frequently asked questions
- What does Eton Pharmaceuticals do?
- Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products, including injectable and rare disease treatments. Its leadership team has experience across pharmaceutical product development, commercialization, quality/GxP compliance, and finance.
- Who founded Eton Pharmaceuticals?
- Eton Pharmaceuticals was founded by Sean E. Brynjelsen in 2017.
- How much funding has Eton Pharmaceuticals raised?
- Eton Pharmaceuticals has disclosed $27.6M raised across 2 rounds.
- Where is Eton Pharmaceuticals headquartered?
- Eton Pharmaceuticals is headquartered in San Diego, US.






